Aviva Ventures
Sequoia, MassMutual lead Series B for Singapore's Biofourmis
Sequoia Capital India and MassMutual Ventures have led a $35 million Series B round of funding for Singapore-based Biofourmis, operator of a health analytics platform that tracks how patients are responding to treatment.